A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1
Richard Crook(Mayo Clinic in Florida), Matti Haltia(University of Helsinki), John Hardy(UK Dementia Research Institute), Minna Pöyhönen(Väestöliitto), Nitin D. Mehta(Jacksonville College), Mirja Somer(Väestöliitto), Matthew J. Farrer(University of Florida), Matt Baker(Mayo Clinic in Florida), Hannu Kalimo(University of Turku), Jordi Pérez‐Tur(Universidad Cardenal Herrera CEU), Katrina Gwinn(Mayo Clinic in Arizona), Raija Ylikoski(Helsinki University Hospital), Henry Houlden(Queen Mary University of London), Sarah Lincoln(Jacksonville College), Mike Hutton(Salisbury District Hospital), Auli Verkkoniemi(Helsinki University Hospital), Steve Kucera(University of Tampa), Anders Paetau(Helsinki University Hospital)
Cited by 349
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k